Show simple item record

dc.contributor.authorWhite, DL
dc.contributor.authorAdams, P
dc.contributor.authorAltes, A
dc.contributor.authoret al,
dc.date.accessioned2018-03-29T08:11:22Z
dc.date.issued2018-03-27
dc.identifier.issn1936-0533
dc.identifier.issn1936-0541
dc.identifier.urihttp://hdl.handle.net/10026.1/11209
dc.description.abstract

Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.

dc.format.extent83-86
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoen
dc.publisherSpringer Verlag
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectChelation Therapy
dc.subjectDiet
dc.subjectHemochromatosis
dc.subjectHemochromatosis Protein
dc.subjectHomozygote
dc.subjectPhlebotomy
dc.titleTherapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29589198
plymouth.issue2
plymouth.volume12
plymouth.publisher-urlhttp://dx.doi.org/10.1007/s12072-018-9855-0
plymouth.publication-statusPublished
plymouth.journalHepatology International
dc.identifier.doi10.1007/s12072-018-9855-0
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Health Professions
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2018-03-15
dc.identifier.eissn1936-0541
dc.rights.embargoperiodNo embargo
rioxxterms.versionofrecord10.1007/s12072-018-9855-0
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-03-27
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV